Patent Opposition Database

Join our community to challenge unmerited drug patents

  1. Home
  2. Drugs
  3. Dolutegravir/Rilpivirine (Juluca)
  4. Fundación Grupo Efecto Positivo (Fgep) Opposition, Dolutegravir/Rilpivirine, (Ar112213 A1 (P20180101799) )

Fundación Grupo Efecto Positivo (Fgep) Opposition, Dolutegravir/Rilpivirine, (Ar112213 A1 (P20180101799) )

Download Pdf Subscribe to updates

No Annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number)
AR112213A1 (P20180101799)
Who filed
Fundación Grupo Efecto Positivo (FGEP)
Country
Argentina
Opposition type
Pre-Grant
Opposition status
Granted
Date
08-07-2025
Patent type
Formulations
No Annotations

Add an annotation

Where in the document

Click within the document, or manually enter the page number below

Be as descriptive as necessary

Cancel

10 similar patent oppositions